A.S. Vanniasinghe, N. Manolios, S. Schibeci, C. Lakhiani, E. Kamali-Sarvestani, R. Sharma, V. Kumar, M. Moghaddam, M. Ali, V. Bender
Clinical Immunology, Volume 151, Issue 1, March 2014, Pages 43–54
Read the full article on Science Direct – free access until xxx 2014
Nicholas Manolios, MD, PhD, is Professor and Head of the Department of Rheumatology at the Westmead Hospital and University of Sydney, Australia. He is a clinical rheumatologist and immuno-pathologist with an interest in the role of transmembrane charged amino acids on protein-protein/lipid interactions and subsequent cellular function. Current research interests are in the therapeutic application of peptides to influence T-cell antigen receptor biology and how to specifically deliver peptides to sites of joint inflammation using nanoparticles.